Infectious Diseases Consultant spoke with Helen Kelly, PhD, about her recent study, which suggested that early initiation and effective use of ART at high nadir CD4 counts may be associated with decreased...
Andrew D. Redd, PhD, from the National Institutes of Health, answers our questions about his team’s research on HIV transmission clusters and how the findings may impact the future management of HIV.
Infectious Diseases Consultant spoke with Paul K. Drain, MD, an associate professor at the University of Washington, whose new study indicated that point-of-care viral load testing can both simplify...
In this video, Lindsay T. Fourman, MD, talks about the key take-away messages regarding liver fibrosis in patients with HIV and NAFLD, which was published at CROI 2020.
In this podcast, Infectious Diseases Consultant Advisory Board Member Daniel Eiras, MD, discusses his experience with treating patients in New York City amid the COVID-19 pandemic, and how the pandemic has...
Jane Yee, MD, answers our questions about the prevention of COVID-19 among patients with HIV, the risks these patients may face if they are exposed to the novel coronavirus, and the importance of ensuring...
In this video, Lindsay T. Fourman, MD, talks about how non-alcoholic fatty liver disease affects patients with HIV differently than it effects the general public.
In this podcast, Bill Kapogiannis, MD, discusses the multi-Federal agency SMILE Collaborative (Strategic Multisite Initiative for the Identification, Linkage and Engagement in Care of HIV-infected youth),...
